UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055832
Receipt number R000063812
Scientific Title Effectiveness of pulmonary telerehabilitation in preventing rehospitalization for patients with chronic respiratory disease: a prospective cohort study
Date of disclosure of the study information 2024/10/15
Last modified on 2025/07/14 11:35:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of pulmonary telerehabilitation for early social implementation and evaluation of its effectiveness in preventing rehospitalization

Acronym

Effectiveness of pulmonary telerehabilitation in preventing rehospitalization

Scientific Title

Effectiveness of pulmonary telerehabilitation in preventing rehospitalization for patients with chronic respiratory disease: a prospective cohort study

Scientific Title:Acronym

Effectiveness of pulmonary rehabilitation in preventing rehospitalization for patients with chronic respiratory disease

Region

Japan


Condition

Condition

Chronic respiratory diseases

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop a minimal-resource system for pulmonary telerehabilitation (PTR) based on information and communication technology (ICT), utilizing the patient's residential environment without the need for specialized exercise therapy equipment. The effectiveness of this system will be evaluated in terms of its ability to prevent rehospitalization.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

All-cause readmission within 90 days of discharge

Key secondary outcomes

Lower limb muscle strength (30-second chair standing test)
Physical activity (average number of steps per day, duration of activity by intensity)
Health-related quality of life (COPD Assessment Test, St.Geoge's Respiratory Questionnaire)
Anxiety and Depression (Hospital Anxiety and Depression Scale)
PTR implementation status (number of times the program was implemented, rehabilitation interruptions and their reasons)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

The following respiratory rehabilitation protocol, which utilizes the patient's home environment as a resource, will be implemented in a format adapted for PTR. Duration: 40-60 minutes per session, frequency: 2 sessions per week, duration: 13 weeks. Program: The physical therapist will monitor the following exercises through the screen of the patient's tablet device: breathing exercises, chair rise exercises, calf raises, half squats, upper limb raising exercises, and physical activity guidance.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Those deemed eligible for post-discharge pulmonary rehabilitation by a physician
Those who can sufficiently understand how to use the remote system equipment
For those with hearing impairments or who cannot fully understand how to use the equipment, a family member who can assist with the implementation of PTR is required

Key exclusion criteria

Severe physical frailty (Japanese version of the Clinical Frailty Scale > 6)
Sserious comorbidities (e.g., pulmonary hypertension, malignant tumors)

Target sample size

26


Research contact person

Name of lead principal investigator

1st name Kazuaki
Middle name
Last name Suyama

Organization

Reiwa Health Sciences University
Nagasaki University Graduate School of Biomedical Sciences

Division name

Faculty of Rehabilitation

Zip code

811-0213

Address

2-1-12 Wajirogaoka, Higashi-ku, Fukuoka City, Fukuoka Prefecture, Japan

TEL

092-607-6701

Email

kazuaki.suyama@rhs-u.ac.jp


Public contact

Name of contact person

1st name Kazuaki
Middle name
Last name Suyama

Organization

Reiwa Health Sciences University

Division name

Faculty of Rehabilitation

Zip code

811-0213

Address

2-1-12 Wajirogaoka, Higashi-ku, Fukuoka City, Fukuoka Prefecture, Japan

TEL

092-607-6701

Homepage URL


Email

kazuaki.suyama@rhs-u.ac.jp


Sponsor or person

Institute

Reiwa Health Sciences University

Institute

Department

Personal name

Kazuaki Suyama


Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Nagasaki University Graduate School of Biomedical Sciences, Tagami Hospital, Inoue Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Reiwa Health Sciences University Ethics Committee

Address

2-1-12 Wajirogaoka, Higashi-ku, Fukuoka City, Fukuoka Prefecture, Japan

Tel

092-607-6706

Email

krinri@rhs-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

田上病院(長崎県)、井上病院(長崎県)


Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 10 Month 10 Day

Date of IRB

2024 Year 10 Month 10 Day

Anticipated trial start date

2024 Year 10 Month 10 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 10 Month 15 Day

Last modified on

2025 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063812